"The establishment of the Obesity Association, and now its associated journal, marks a significant advancement toward a future where the management of cardiometabolic diseases is unified, proactive, ...

Diabeloop receives FDA 510(k) clearance for DBLG2, an Automated Insulin Delivery algorithm in an App: a strategic ...

Clinical trials underrepresent women, children, and adults aged 65 years or older, so diabetes guidelines must be adapted to ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down.

Intensive treatment to control systolic blood pressure (BP) to less than 120 mmHg significantly reduced the incidence of major cardiovascular events in patients over the age of 50 with type 2 diabetes ...

An experimental drug compound could be a promising treatment for harmful diabetes complications, per a new study in lab mice and human cells. When you purchase through links on our site, we may earn ...

An extract from a desert berry used in traditional Chinese medicine restored insulin function and stabilized metabolism in diabetic mice. The findings hint at a powerful natural alternative for ...

ST. PAUL, Minn., Nov. 6 (UPI) --Positive results from a late-stage clinical trial released Thursday have raised hopes that type 1 diabetes patients who suffer from chronic kidney disease will have a ...

It’s estimated that 38.4 million Americans live with diabetes, according to the U.S. Centers for Disease Control & Prevention. Diabetes is a major risk factor for heart disease, kidney disease and ...

Background: Persons with chronic kidney disease (CKD) and type 2 diabetes (T2D) face high but modifiable risks of incident heart failure (HF). The HFpEF-ABA algorithm, originally developed for HFpEF ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc may also help prevent heart disease by lowering cholesterol and reducing ...